Green tea consumption and risk of depressive symptoms: Results from the TCLSIH Cohort Study
Xinrong Dong,Yeqing Gu,Sabina Rayamajhi,Amrish Thapa,Ge Meng,Qing Zhang,Li Liu,Hongmei Wu,Shunming Zhang,Tingjing Zhang,Xuena Wang,Huiping Li,Juanjuan Zhang,Jun Dong,Xiaoxi Zheng,Zhixia Cao,Shaomei Sun,Xing Wang,Ming Zhou,Qiyu Jia,Kun Song,Hong Chang,Yunliang Zheng,Kaijun Niu
DOI: https://doi.org/10.1016/j.jad.2022.04.112
IF: 6.533
2022-04-01
Journal of Affective Disorders
Abstract:BackgroundThe prospective studies on the effect of particular type of tea consumption, especially green tea, on depressive symptoms are limited.ObjectiveThe aim of this study is to investigate the prospective association between green tea consumption and depressive symptoms in a large general adult population.MethodsThis prospective cohort study investigated 7524 participants aged 25 to 90 years from May 2013 to December 2018 and they were free of cardiovascular disease, cancer, and depressive symptoms at baseline. Green tea consumption was obtained through a validated food frequency questionnaire. Depressive symptoms were assessed by using the Self-Rating Depressive Scale (SDS). The association between green tea consumption and depressive symptoms was analyzed by Cox proportional hazards regression models.ResultsA total of 1064 first incident cases of depressive symptoms (SDS ≥45) occurred during 14,661 person-years of follow-up (median follow-up of 2.0 years). In the crude model, the hazard ratios (95% confidence intervals) were 1.00 (reference), 0.95 (0.81, 1.12), 0.97 (0.83, 1.14) and 0.95 (0.79, 1.14), respectively. After adjusting for demographic characteristics, lifestyle factors, and dietary intake, the multivariable adjusted hazard ratios (95% confidence intervals) were 1.00 (reference), 0.88 (0.74, 1.05), 0.84 (0.69, 1.02) and 0.78 (0.63, 0.97), respectively.ConclusionsThe prospective study suggests that frequent green tea consumption is associated with a decreased risk of depressive symptoms in the general Chinese population.
psychiatry,clinical neurology